Randomised trial of interferon alfa-1b plus ribavirin for 48 weeks or for 24 weeks versus interferon alfa-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. - Poynard,T.; Marcellin,P.; Lee,S.S. (Lancet, 1998)